Sarofim Fayez’s Teva Pharmaceuticals TEVA Stock Holding History

Sarofim Fayez’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$232K	Buy	+6,150	New	+$240K	﹤0.01%	220

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Sarofim Fayez's TEVA Position: Q3 2013 in Review

Sarofim Fayez opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2013: 6,150 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #220 among its holdings.

705 funds tracked by Wall St. Rank hold TEVA as of Q3 2013.

Sarofim Fayez held 6,150 shares of Teva Pharmaceuticals worth $232K as of Q3 2013.
Teva Pharmaceuticals was a new Sarofim Fayez position in Q3 2013.
Teva Pharmaceuticals made up ﹤0.01% of Sarofim Fayez's portfolio in Q3 2013, its #220 holding.
705 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.